SP086NEBIVOLOL AND IRBESARTAN REDUCE POST-HEMODIALYSIS AND AMBULATORY BP IN PATIENTS WITH INTRADIALYTIC HYPERTENSION: A RANDOMIZED CROSS-OVER STUDY

Authors :: Pantelis Sarafidis
Vasilios Liakopoulos
Aikaterini Papagianni
Elena Aggeloudi
Charalampos Loutradis
Ploumis Pasadakis
Elias V. Balaskas
Athanasios Bikos
Antonios Karpetas
Vasilios Raptis
Evdoxia Ginikopoulou
Stylianos Panagoutsos
Source :: Nephrology Dialysis Transplantation. 33:i374-i374
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: Transplantation
medicine.medical_specialty
business.industry
medicine.medical_treatment
Crossover study
Nebivolol
Irbesartan
Nephrology
Internal medicine
Ambulatory
Medicine
In patient
Hemodialysis
business
medicine.drug

Full Text Access

Tools